• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

NUS researcher inducted into prestigious EMBO Young Investigator Program

Bioengineer by Bioengineer
November 20, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: National University of Singapore

Assistant Professor Polly Leilei Chen, who is from the National University of Singapore's (NUS) Yong Loo Lin School of Medicine and the Cancer Science Institute of Singapore (CSI Singapore), has been inducted into the prestigious Young Investigator Programme, an initiative under the European Molecular Biology Organization (EMBO).

Asst Prof Chen, whose work primarily focuses on research in ribonucleic acid (RNA) biology and human cancer, is the only Singapore-based scientist among this year's awardees and she joins 25 other life science researchers from 10 countries who will receive support from EMBO during the foundation of their first independent laboratory.

The EMBO Young Investigator Programme identifies recent group leaders with proven record of scientific excellence and offers them access to a range of benefits during their four-year tenure. These include a funding award and practical support such as mentorship by a senior from the community, access to training in leadership skills and responsible research practices, as well as networking opportunities.

Asst Prof Chen joined CSI Singapore as a Senior Research Scientist in 2012, and she became a fully independent Principal Investigator in June 2014. She now leads a team studying epigenetic mechanisms such as RNA editing and its role in cancer development. Asst Prof Chen is also a faculty member of the Department of Anatomy at the NUS Yong Loo Lin School of Medicine. In 2014, she received the NUS Young Investigator Award, and in the following year, she was conferred the NUS President Assistant Professorship in recognition of her exceptional research profile and strong trajectory as a very highly qualified junior faculty.

She was among a group of investigators to first describe RNA editing dysregulation in human cancers including liver, stomach and esophageal cancer. Together with her team, Asst Prof Chen has gained international recognition for their work. She has been invited to speak at several international conferences, such as the 73rd Annual Meeting of the Japanese Cancer Association in 2014 and the 2017 Gordon Research Conference on RNA Editing – the most renowned conference in the area of RNA editing research.

Among her notable novel scientific contributions include the discovery of the links between RNA editing imbalance and tumorigenesis in three types of gastrointestinal cancers, as well as the uncovering of a previously undescribed mechanism in which a group of enzymes (Adenosine DeAminases acting on double-stranded RNA enzymes also known as ADAR enzymes) regulate the expression of cancer-related genes. Her discovery of the first bidirectional regulator of A-to-I RNA editing and characterising the functional roles of the DHX9 gene also further helped unravel that the regulation of A-to-I RNA editing is much more complex than previously anticipated.

"The focus of my current and future research has been placed on projects which could answer the long-standing questions in the area of RNA editing research, such as the non-ADAR regulators of A-to-I RNA editing and the substrate selectivity and sensitivity of ADAR," said Asst Prof Chen. "As a young independent investigator, I am personally and passionately committed to becoming a world expert in RNA editing in cancer. Findings from my research has the potential to directly lead to new insights into etiology of tumorigenesis, further providing useful targets for early diagnosis and help develop RNA-based therapeutics, ultimately making a difference in the lives of cancer patients, which fits well with the major health problem in the world."

"I am honoured to be selected and inducted into the EMBO Young Investigator Programme. With its backing, I can receive extensive support for networking interactions in the form of visits, student exchanges or joint group meetings and other career development opportunities," she added.

###

Media Contact

Amal Naquiah
[email protected]
65-651-65125
@NUSingapore

http://www.nus.edu.sg/

Original Source

http://news.nus.edu.sg/press-releases/NUS-researcher-embo-young-investigator

Share12Tweet8Share2ShareShareShare2

Related Posts

Coronary Artery Calcium: A Potential Indicator of Overall Mortality Beyond Heart Disease

Coronary Artery Calcium: A Potential Indicator of Overall Mortality Beyond Heart Disease

November 8, 2025

Analyzing Adult Autism Diagnoses on TikTok

November 8, 2025

Selective Decoction Alters Chemical Profile of Palmijihwang-tang

November 8, 2025

Minimally Invasive Coronary Calcium CT Scans Detect Additional Health Issues Beyond Heart Disease Risk

November 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    314 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    206 shares
    Share 82 Tweet 52
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1302 shares
    Share 520 Tweet 325
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Coronary Artery Calcium: A Potential Indicator of Overall Mortality Beyond Heart Disease

Analyzing Adult Autism Diagnoses on TikTok

Selective Decoction Alters Chemical Profile of Palmijihwang-tang

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.